In this paper a method is presented which is suitable for the extraction, purification and analysis of serum gangliosides. The advantage in comparison with other previously published procedures is the complete extraction of sialoglycolipids without contamination of sialoglycoproteins and/or sialoglycopeptides. The method could be used as a second-level test for the diagnosis and follow-up of cancer patients, and also could be potentially used for pharmaco-kinetic studies after ganglioside treatment.
StefanelliN., KlotzH., EngelA., BauerP.. Serum sialic acid in malignant tumors, bacterial infections and chronic liver diseases.J Cancer Res Clin Oncol1985; 109: 55–9.
2.
BerraB., OmodeoSale’ M.F., RapelliS.. Tissue and serum glycoconjugates composition in human meningiomas (Abstract).J Cell Biochem1989 (Suppl 13A): B400.
3.
PlucinskyM.C., RileyW.M., ProrokJ.J., AlhadeffJ.A.. Total and lipid - associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement.Cancer1986; 58: 110–5.
4.
VaianiG., LocatelliE., SensalariG., MontiM., ReggianiS., CuniettiE.. Plasma lipid-bound sialic acid and carcinoembryonic antigen in cancer patients. Individual and combined clinical usefulness as tumor markers.J Exp Clin Cancer Res1987; 6, 3: 195–8.
5.
RavindranathM.H., IrieR.F.. Gangliosides as antigens of human melanoma.Cancer Treat Res1988; 43: 17–43.
6.
HakomoriS.I.. Tumor-associated glycolipid antigens, their metabolism and organization.Chem Phys Lipids1986; 42: 209–33.
7.
YogeeswaranG.. Cell surface glycolipids and glycoproteins in malignant transformation.Adv Cancer Res1983; 38: 289–310.
SpiegelS., FishmanP.H.. Gangliosides as bimodal regulators of cell growth. Proc Natl Acad Sci.USA1987; 84: 141–5.
10.
SvennerholmL.. Immunological and tumoral aspects of gangliosides. In: LedeenR.W., HoganE.L., TettamantiG., YatesA.J., YuR.K., eds. New trends in ganglioside research.Padova: Liviana Press1988; 135–50. (Fidia research series: vol. 14).
11.
LadischS., GillardB., WongC., UlshL.. Shedding and immunoregulatory activity of YAC-1 lymphoma cell gangliosides.Cancer Res1983; 43: 3808–13.
12.
ShaposhnikovaG.I., ProkazovaN.V., BuznikovG.A., ZvezdinaN.D., TeplitzN.A., BergelsonL.D.. Shedding of gangliosides from tumor cell depends on cell density.Eur J Biochem1984; 140: 567–70.
13.
HakanssonL., FredmanP., SvennerholmL.. Gangliosides in serum immunocomplexes from tumor-bearing patients.J Biochem1985; 98: 843–9.
14.
LadischS., WuZ.L., FeigS.. Shedding of GD2 ganglioside by human neuroblastoma.Int J Cancer1987; 39: 73–6.
15.
VinzenzK.. Diagnosis of head and neck carcinomas by means of immunological tumor markers.J Cranio Max Fac Surg1987; 15: 270–7.
16.
CoppaG.V., ZampiniL., GranchiD., RapelliS., BerraB.. L'acido sialico può essere considerato un marker di tumori nell'età evolutiva? Problemi e prospettive.Riv ItalPed (UP)1987; 13; 208–9.
17.
KatopodisN., StockC.C.. Improved method to determine lipid bound sialic acid in plasma or serum.Res Comm Chem Pathol Pharmacol1980; 30: 171–80.
18.
PatsnerB., FacogM.D., MannW.J.. Comparison of serum CA-125 and lipid-associated sialic acid (LASA-P) in monitoring patients with invasive ovarian adenocarcinoma.Gynecol Oncol1988; 30: 98–103.
19.
SchwartzP.E., ChambersS.K., ChambersJ.T., GutmannJ., KatopodisN., FoemmelR.. Circulating tumor markers in the monitoring of gynecologic malignancies.Cancer1987; 60: 353–61).
20.
GinsbourgM., MussetM., MissetJ.L., MatheG.. Relationship between proliferative activity of bone marrow micrometastasis and plasmatic level of a new cancer marker- lipid associated sialic acid.Biomed Pharmacoter1986; 40: 388–91.
21.
BerraB., RapelliS., MonticelliG.. Usefulness and potential pitfalls of sialic acid determination in sera of patients with ovarian tumors.Int J Biol Markers1986; 1: 39–46.
22.
BerraB., RapelliS., RinghiniR., BombardieriE.. Determinazione dell'acido sialico di pazienti affetti da tumori.Biochim Clin1986; 10(Suppl 11): 391–7.
23.
LadischL., GillardB.. Isolation and purification of gangliosides from plasma. In: Ginsburg V, ed. Methods in Enzymology.Academic Press1987; 138: 300–306.
24.
BerraB., RapelliS.. Usefulness and pitfalls of sialic acid determination in serum of patients with tumors. In: GaleottiT., ed. Cells Membranes and Cancer.Elsevier Publ. Co.1985; 125–8.
25.
BrunngraberE.G., TettamantiG., BerraB.. Extraction and analysis of material containing lipid-bound sialic acid. In: WittingL.A., ed. Glycolipid Methodology.American Oil Chemist's Society1976; 159–86.
26.
SvennerholmS., FredmanP.. A procedure for the quantitative isolation of brain gangliosides.Biochim Biophys Acta1980; 617: 97–109.
27.
LowryO.H., RosebroughtN.J., FarrA., RandallR.. Protein measurement with Folin phenol reagent.J Biol Chem1985; 193: 265–75.
28.
WinzlerR.J.. Determination of serum glycoproteins.Methods of Biochem Analysis1955; 2: 279–311.
29.
TettamantiG., BonaliF., MarchesiniS., ZambottiV.. A new procedure for extraction, purification and fractionating of brain gangliosides.Biochim Biophys Acta1973; 296; 160–70.
30.
SuzukiK.. Pattern of mammalian brain gangliosides II.J Neurochemistry1965; 12: 629–38.
31.
WilliamsM.A., Mc CluerR.H.. The use of Sep-Pak C18 cartridges during the isolation of gangliosides.J Neu-rochem1980; 35: 266–9.
32.
RouserG., KritchevskyG., YamamotoA.. Column chromatographic and associated procedures for separation and determination of phosphatides and glycolipids. In: Marinetti GV, ed. Lipid Chromatographic Analysis.New York: Dekker1967; 1: 99–162.
33.
PearsonS., SternS., GavackT.M.. A rapid, accurate method for the determination of total cholesterol.Analytical Chemistry1953; 25: 313–4.
34.
BartlettG.R.. Phospholipids assay in column chromatography.J Biol Chem1959; 234: 466–8.
35.
BerraB., RapelliS.. Struttura e funzioni degli acidi sialici e loro utilizzazione come markers tumorali. In: CorradoF., MaltoniC., FerriC., PaladiniG., BurraggiG.L., CarrettiD., eds. Markers Tumorali.Monduzzi1985; 41–50.
36.
BerraB., RapelliS., RiboniL.. Serum sialic acid determination for the diagnosis and follow up of patients with intracranial tumors. VI European Winter Conference on Brain Research. Avoriaz (France), March 1986.
37.
BerraB., Della MeaI., RapelliS.. Preliminary results on the follow up by the determination of blood sialic acid of patients with different tumors. III International Conference on Human Tumor Markers. Lacco Ameno d'Ischia (Italy), April 1986.
38.
BerraB., RapelliS., GornatiR., MontorfanoG.. A new method for sialoglycoconjugate analysis in serum. VII European Winter Conference on Brain Research. Val Thorens (France), March 1987.
39.
RapelliS., BerraB.. Usefulness and pitfalls of sialic acid determination in serum of patients with brain tumors. V European Winter Conference on Brain Research. Vars-Les-Claux (France), March 1985.
40.
RapelliS., GornatiR., MontorfanoG., BerraB.. Serum sialoglycoconjugates determination: a useful tool for tumor diagnosis follow up? IX International Symposium on Glycoconjugates. Lille (France), July 1987.
41.
RapelliS., GornatiR., MontorfanoG.. Glicoconiugati tissutali e serici in pazienti con meningiomi. XXXIV Congresso SIB. Padova (Italy), October 1988, 188.
42.
LadishS., ZiLiang Wu. Detection of a tumor associated ganglioside in plasma of patients with neuroblastoma.Lancet1985; 1: 36–8.
